Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FORUM allogeneic stem cell transplantation in children and adolescents with acute lymphoblastic leukemia
NL-OMON59153Phase 3Recruiting
- Sponsor
- St. Anna Children's Cancer Research Institute
- Start
- Oct 2024
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of fludarabine, thiotepa, busulfan, treosulfan and etoposide in acute lymphoblastic leukemia (ALL) (4 arms), sponsored by St. Anna Children's Cancer Research Institute. Primary endpoints: Overall survival and Event-free survival. Started Oct 2024; status: recruiting.
02
Drugs
fludarabinethiotepabusulfantreosulfanetoposide
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NL-OMON59153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59153.